Publication | Closed Access

Expression of a 150-kD cell surface antigen identified by monoclonal antibody YB5.B8 is associated with poor prognosis in acute non-lymphoblastic leukaemia

Hematological MalignancyLymphoid NeoplasiaMonoclonal Antibody Yb5.b8Acute Non-lymphoblastic LeukaemiaMixed-phenotype Acute LeukemiaHematologyImmunologyPathologyPoor PrognosisAdult T-cell Leukemia-lymphomaMedicineTumor Biology